Stock price when the opinion was issued
Phenomenal compounder. Unique business model. Via its capital allocation infrastructure, king of doing the small deals that private equity can't do. Grows at an exceptionally high rate, rarely goes on sale. Look at its price to cashflow, with 3% being his threshold free cashflow yield. Right now, it's around 2.3-2.5%, which is above his buy price.
Definitely buy on a pullback, and hold for a very long time.
Really big move, a leader to the upside. Now showing signs of stalling and breaking down. Reaffirms his view that we're in a corrective phase. Moved below the 200-day MA, not a great sign. Doesn't mind nibbling here, but expects a better opportunity in the next 1-2 months as we get through September and even into October.
He'd definitely be looking to add around $4250, the support level of the tariff tantrum back in April.
Very aggressive M&A strategy. Some of the best capital allocators in the business. Optimizes costs in acquisitions to increase margins, but doesn't necessarily invest in growth. So organic revenue has struggled, and we need to analyze how long this will last. Vertical synergy strategy works well.
Key metric to look for is reacceleration of organic revenue, rather than just M&A revenue.
Utmost confidence in management. Massive compounding shareholder value over time. Recent results were good. Behind the pace on M&A goal for the year. Could be getting lost amidst AI-driven stories. Vertical markets mean its organic growth rate is low.
Continues to be long and strong. Not concerned by recent pullback.
She doesn't know why either :) Valuation is pretty high. Strong management team. Her firm stays away from companies that are just focused on M&A growth. M&A works until it doesn't. As a company gets bigger, so do the acquisitions in order to move the needle.